Physician

Amit Malhotra, M.D.

According to 2025 Medicare claims, Amit Malhotra, M.D. (NPI: 1699724294) practices interventional cardiology in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from De Soto, MS. This provider's primary affiliated billing organization is STERN CARDIOVASCULAR FOUNDATION, INC (NPI: 1316242266; TIN: 274396698) and primary practice location at 38671-9998. Malhotra is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and Baptist Connected Care Solutions, Inc. (ACO ID: A5693), participating under the MSSP model.

Malhotra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,836 traditional Medicare patients, billed 7,291 HCPCS/CPT codes, and received $315,267 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,806 prescription claims across 1,644 beneficiaries totaling $2,924,270 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 14 claims. Open Payments data shows 87 records totaling $2,261. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $533,859 to $315,267. In contrast, Part D prescription costs have moved sharply higher in recent years, from $676,726 to $2,924,270. For DME billing, this smaller-volume category moved from a higher plateau to a lower plateau, from $76,478 to $7,462.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,029	10,315	$533,859
2016	1,939	10,573	$472,470
2017	1,907	12,858	$523,224
2018	1,706	12,250	$487,360
2019	1,689	11,006	$385,054
2020	1,825	9,913	$374,683
2021	2,062	9,361	$387,872
2022	1,951	8,791	$355,072
2023	2,001	11,239	$380,982
2024	1,836	7,291	$315,267

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,013	14,660	$676,726
2016	1,041	14,688	$822,356
2017	1,108	13,622	$944,442
2018	1,199	15,010	$1,080,891
2019	1,262	13,729	$1,237,949
2020	1,451	16,718	$1,699,679
2021	1,572	15,564	$1,872,846
2022	1,654	15,989	$2,213,277
2023	1,632	16,019	$2,874,769
2024	1,644	15,806	$2,924,270

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	121	$75,786
2016	N/R	118	$62,314
2017	14	169	$85,343
2018	N/R	97	$34,977
2019	N/R	111	$9,536
2020	N/R	44	$2,590
2021	N/R	34	$1,372
2022	N/R	14	$882
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,218	1,957	$81
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	724	739	$50
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	242	243	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	938	1,181	$9
36415	Insertion of needle into vein for collection of blood sample	290	324	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	845	41,753	$807,273
Entresto	Sacubitril/Valsartan	643	30,304	$581,391
Farxiga	Dapagliflozin Propanediol	357	18,085	$338,007
Jardiance	Empagliflozin	332	16,922	$322,165
Xarelto	Rivaroxaban	299	13,662	$254,285

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$2,261	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amit Malhotra, M.D.?

Tedicare shows public-source Medicare data for Amit Malhotra, M.D. (NPI 1699724294), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Malhotra, M.D. have ACO affiliation data?

Amit Malhotra, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645) and Baptist Connected Care Solutions, Inc. (MSSP, ACO ID A5693).

What billing organization is linked to Amit Malhotra, M.D.?

Amit Malhotra, M.D. is linked to STERN CARDIOVASCULAR FOUNDATION, INC (billing NPI 1316242266) in the available physician profile data.

Does Amit Malhotra, M.D. have Open Payments data?

Amit Malhotra, M.D. has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.